Michael J. LaBarre
CIK 1507174 · SVP, CHIEF TECHNICAL OFFICER · last filed 2025-02-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
65
Lifetime Open-Market Net
-$25.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | SVP, CHIEF TECHNICAL OFFICER | 173,856 | — | — | -$25.16M | 65 | 2025-02-27 |
Recent Filings · Page 6 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-12-21 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −12,000 | -$510.9K | EDGAR |
| 2020-11-20 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −12,000 | -$465.2K | EDGAR |
| 2020-10-20 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −12,000 | -$365.1K | EDGAR |
| 2020-09-21 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −12,000 | -$322.9K | EDGAR |
| 2020-08-20 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −12,000 | -$339.6K | EDGAR |
| 2020-07-20 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −12,000 | -$348.1K | EDGAR |
| 2020-05-22 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Exer (M) | +18,613 | $132.9K | EDGAR |
| 2020-05-21 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | — | -$356.4K | EDGAR |
| 2020-02-24 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +5,759 | -$66.5K | EDGAR |
| 2020-02-18 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +3,777 | -$42.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.